These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 18301123

  • 21. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.
    Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1219-23. PubMed ID: 17532106
    [Abstract] [Full Text] [Related]

  • 22. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.
    Gigante AD, Lafer B, Yatham LN.
    CNS Drugs; 2012 May 01; 26(5):403-20. PubMed ID: 22494448
    [Abstract] [Full Text] [Related]

  • 23. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania.
    Sajatovic M, DiGiovanni SK, Bastani B, Hattab H, Ramirez LF.
    Psychopharmacol Bull; 1996 May 01; 32(1):55-61. PubMed ID: 8927675
    [Abstract] [Full Text] [Related]

  • 24. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun 01; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 25. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.
    Clin Ther; 2009 Apr 01; 31(4):836-48. PubMed ID: 19446157
    [Abstract] [Full Text] [Related]

  • 26. Clinical experience and management considerations with long-acting risperidone.
    Parellada E.
    Curr Med Res Opin; 2006 Feb 01; 22(2):241-55. PubMed ID: 16466596
    [Abstract] [Full Text] [Related]

  • 27. Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
    Nesvåg R, Hendset M, Refsum H, Tanum L.
    Acta Psychiatr Scand; 2006 Jul 01; 114(1):21-6. PubMed ID: 16774657
    [Abstract] [Full Text] [Related]

  • 28. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR.
    Med Care; 2007 Jun 01; 45(6):545-52. PubMed ID: 17515782
    [Abstract] [Full Text] [Related]

  • 29. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG, Peselow E, Mulcare L, Case BG, Fieve R.
    Bipolar Disord; 2007 Aug 01; 9(5):435-42. PubMed ID: 17680913
    [Abstract] [Full Text] [Related]

  • 30. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
    Wu CS, Hsieh MH, Tang CH, Chang CJ.
    J Affect Disord; 2016 Jun 01; 197():189-95. PubMed ID: 26994437
    [Abstract] [Full Text] [Related]

  • 31. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec 01; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 32. Use of long-acting risperidone in the treatment of bipolar patients.
    Savas HA, Yumru M, Ozen ME.
    J Clin Psychopharmacol; 2006 Oct 01; 26(5):530-1. PubMed ID: 16974200
    [No Abstract] [Full Text] [Related]

  • 33. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.
    J Clin Psychopharmacol; 2008 Dec 01; 28(6):625-30. PubMed ID: 19011430
    [Abstract] [Full Text] [Related]

  • 34. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C, Reymann JM, Frémaux T, Polard E, Séveno T, Bentué-Ferrer D.
    Therapie; 2008 Dec 01; 63(5):359-75. PubMed ID: 19154706
    [Abstract] [Full Text] [Related]

  • 35. What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?
    Samalin L, Nourry A, Charpeaud T, Llorca PM.
    Nord J Psychiatry; 2014 May 01; 68(4):227-35. PubMed ID: 23795859
    [Abstract] [Full Text] [Related]

  • 36. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P, Bret MC, Queuille E.
    Encephale; 2009 Apr 01; 35(2):129-38. PubMed ID: 19393381
    [Abstract] [Full Text] [Related]

  • 37. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME.
    J Clin Psychiatry; 2008 Apr 01; 69 Suppl 5():28-35. PubMed ID: 19265638
    [Abstract] [Full Text] [Related]

  • 38. Risperidone long-acting injection: in bipolar I disorder.
    Deeks ED.
    Drugs; 2010 May 28; 70(8):1001-12. PubMed ID: 20481656
    [Abstract] [Full Text] [Related]

  • 39. Depot neuroleptics and manic depressive psychosis.
    Lowe MR, Batchelor DH.
    Int Clin Psychopharmacol; 1986 Jul 28; 1 Suppl 1():53-62. PubMed ID: 3559161
    [Abstract] [Full Text] [Related]

  • 40. Long-acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers.
    Brietzke E, Lafer B.
    Psychiatry Clin Neurosci; 2011 Mar 28; 65(2):205. PubMed ID: 21414098
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.